bpc-157 human clinical trial evidence review safety studies fda warning trials Thinking about trying BPC-157? bpc 157 evidence clinical trials

BPC-157 has been studied primarily in laboratory animals

NAD+ Reconstitution by Vial Size Vial size 750 mg BAC water added 7.5 mL Final concentration 100 mg/mL Volume per 50 mg 0.50 mL (50 units) Volume per 100 mg 1.00 mL (100 units) Vial size 750 mg BAC water added 4.5 mL Final concentration 166.7 mg/mL Volume per 50 mg 0.30 mL (30 units) Volume per 100 mg 0.60 mL (60 units) Vial size 1,000 mg BAC water added 10.0 mL Final concentration 100 mg/mL Volume per 50 mg 0.50 mL (50 units) Volume per 100 mg 1.00 mL (100 units) Vial size 1,000 mg BAC water added 5.0 mL Final concentration 200 mg/mL Volume per 50 mg 0.25 mL (25 units) Volume per 100 mg 0.50 mL (50 units) Vial size 1,500 mg BAC water added 10.0 mL Final concentration 150 mg/mL Volume per 50 mg 0.33 mL (33 units) Volume per 100 mg 0.67 mL (67 units) Higher-concentration mixes reduce injection volume but require finer measurement on the syringe

Potential Side Effects: Like any medical procedure, B12 injections can have side effects, and without professional guidance, it may be challenging to manage them

Add 2 mL of bacteriostatic water to the 10 mg vial